Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R03BB" (13)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Ipratropium Bromide (R03BB01) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Atrovent 250 mcg/2 ml
60 unidose(s)
17.33
34.85
10 %
Lösung für einen Vernebler (gebrauchsfertige Einzeldosen): Ipratropii Bromidum Anhydricum 250µg / 2ml
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
IP
CI
Atrovent N
200 inhalation(s)
9.52
26.75
10 %
Metered dose aerosol: Ipratropii Bromidum 21 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
CI
Atrovent
15 ml
13.12
29.80
k.A.
Metered dose aerosol: Ipratropii Bromidum 20 µg
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
Tiotropium Bromide (R03BB04) 4 products
WHO-DDD
SIP
IP
CI
Spiriva 18 mcg
30 Capsule(s)
29.98
49.00
10 %
Inhalation Powder: Tiotropium 18 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
SIP
IP
CI
Spiriva 18 mcg
90 Capsule(s)
88.66
112.85
10 %
Inhalation Powder: Tiotropium 18 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Spiriva Respimat 2.5 mcg
29.98
49.00
10 %
Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Spiriva Respimat 2.5 mcg
3
88.66
112.85
10 %
Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Aclidinium Bromide (R03BB05) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Eklira Genuair
piece(s)
37.46
57.15
10 %
Inhalation Powder: Aclidinii Bromidum 375 µg
Covis Pharma GmbH
B / SL
FB
G
IP
CI
PP
Eklira Genuair
3 piece(s)
103.54
129.00
10 %
Inhalation Powder: Aclidinii Bromidum 375 µg
Covis Pharma GmbH
B / SL
FB
G
Glycopyrronium Bromide (R03BB06) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Seebri Breezhaler
30 Capsule(s)
35.38
54.90
10 %
Mikrogramm: Glycopyrronium 50 µg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Seebri Breezhaler
90 Capsule(s)
106.13
131.85
10 %
Mikrogramm: Glycopyrronium 50 µg
Novartis Pharma
Schweiz AG
B / SL
FB
G
Umeclidinium Bromide (R03BB07) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Incruse Ellipta
30 unidose(s)
34.64
54.10
10 %
Inhalation Powder: Umeclidinium 62.5 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Incruse Ellipta
3 x 30 unidose(s)
103.00
128.45
10 %
Inhalation Powder: Umeclidinium 62.5 µg
GlaxoSmithKline AG
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
